Cargando…

Receptors of Advanced Glycation End Product (RAGE) Suppression Associated With a Preserved Osteogenic Differentiation in Patients With Prediabetes

Type 2 diabetes is widely documented for osteogenic differentiation defect and impaired bone quality, which is related to the skeletal accumulation of advanced glycation end products (AGEs). Prediabetes is a condition in which hyperglycemia is lower than the threshold for the diagnosis of diabetes....

Descripción completa

Detalles Bibliográficos
Autores principales:	Phimphilai, Mattabhorn, Pothacharoen, Peraphan, Chattipakorn, Nipon, Kongtawelert, Prachya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882829/ https://www.ncbi.nlm.nih.gov/pubmed/35237235 http://dx.doi.org/10.3389/fendo.2022.799872

Ejemplares similares

Age-Influenced Receptors of Advanced Glycation End Product Overexpression Associated With Osteogenic Differentiation Impairment in Patients With Type 2 Diabetes
por: Phimphilai, Mattabhorn, et al.
Publicado: (2021)

The trajectory of osteoblast progenitor cells in patients with type 2 diabetes and the predictive model for their osteogenic differentiation ability
por: Phimphilai, Mattabhorn, et al.
Publicado: (2023)

Chondroprotective effects of purple corn anthocyanins on advanced glycation end products induction through suppression of NF-κB and MAPK signaling
por: Chuntakaruk, Hathaichanok, et al.
Publicado: (2021)

Sesamin protects against neurotoxicity via inhibition of microglial activation under high glucose circumstances through modulating p38 and JNK signaling pathways
por: Kongtawelert, Prachya, et al.
Publicado: (2022)

Comparison of glucose derivatives effects on cartilage degradation
por: Phitak, Thanyaluck, et al.
Publicado: (2010)

Anticancer Activities of Hesperidin via Suppression of Up-Regulated Programmed Death-Ligand 1 Expression in Oral Cancer Cells
por: Wudtiwai, Benjawan, et al.
Publicado: (2021)

Effects of sesamin on chondroitin sulfate proteoglycan synthesis induced by interleukin-1beta in human chondrocytes
por: Srisuthtayanont, Warunee, et al.
Publicado: (2017)

Alteration of chondroitin sulfate composition on proteoglycan produced by knock-in mouse embryonic fibroblasts whose versican lacks the A subdomain
por: Suwan, Keittisak, et al.
Publicado: (2009)

Sesamin stimulates osteoblast differentiation through p38 and ERK1/2 MAPK signaling pathways
por: Wanachewin, Orawan, et al.
Publicado: (2012)

Comparison of growth factor adsorbed scaffold and conventional scaffold with growth factor supplemented media for primary human articular chondrocyte 3D culture
por: Klangjorhor, Jeerawan, et al.
Publicado: (2014)

Ex vivo model exhibits protective effects of sesamin against destruction of cartilage induced with a combination of tumor necrosis factor-alpha and oncostatin M
por: Khansai, Manatsanan, et al.
Publicado: (2016)

Sesamin Promotes Neurite Outgrowth under Insufficient Nerve Growth Factor Condition in PC12 Cells through ERK1/2 Pathway and SIRT1 Modulation
por: Udomruk, Sasimol, et al.
Publicado: (2020)

The effect of doxycycline on canine hip osteoarthritis: design of a 6-months clinical trial
por: Nganvongpanit, Korakot, et al.
Publicado: (2009)

Inhibitory Effect of Hesperidin on the Expression of Programmed Death Ligand (PD-L1) in Breast Cancer
por: Kongtawelert, Prachya, et al.
Publicado: (2020)

Atorvastatin Attenuates Programmed Death Ligand-1 (PD-L1) Induction in Human Hepatocellular Carcinoma Cells
por: Shwe, Thuzar Hla, et al.
Publicado: (2021)

Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto’s thyroiditis on levothyroxine substitution
por: Csiha, Sára, et al.
Publicado: (2023)

Comparisons between two biochemical markers in evaluating periodontal disease severity: a cross-sectional study
por: Khongkhunthian, Sakornrat, et al.
Publicado: (2014)

Effects of sesamin on primary human synovial fibroblasts and SW982 cell line induced by tumor necrosis factor-alpha as a synovitis-like model
por: Khansai, Manatsanan, et al.
Publicado: (2017)

Association of the receptor for advanced glycation end-products (RAGE) gene polymorphisms in Malaysian patients with chronic kidney disease
por: Wong, Foo Nian, et al.
Publicado: (2016)

The Receptor for Advanced Glycation End Products (RAGE) and the Lung
por: Buckley, Stephen T., et al.
Publicado: (2010)

Glycated hemoglobin variability and the risk of cardiovascular events in patients with prediabetes and type 2 diabetes mellitus: A post‐hoc analysis of a prospective and multicenter study
por: Manosroi, Worapaka, et al.
Publicado: (2023)

Biochemical and Clinical Assessments of Segmental Maxillary Posterior Tooth Intrusion
por: Tasanapanont, Jintana, et al.
Publicado: (2017)

Sesamin Attenuates VEGFA-Induced Angiogenesis via Inhibition of Src and FAK Signaling in Chick Chorioallantoic Membrane Model and Human Endothelial EA.hy926 Cells
por: Keratibumrungpong, Tanyaporn, et al.
Publicado: (2023)

Hyaluronan production and chondrogenic properties of primary human chondrocyte on gelatin based hematostatic spongostan scaffold
por: Klangjorhor, Jeerawan, et al.
Publicado: (2012)

Targeting Human Osteoarthritic Chondrocytes with Ligand Directed Bacteriophage-Based Particles
por: Chongchai, Aitthiphon, et al.
Publicado: (2021)

Role of receptor for advanced glycation end products (RAGE) in liver disease
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015)

Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
por: Taneja, Sakshi, et al.
Publicado: (2021)

Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients
por: Lazzari, Tássia Kirchmann, et al.
Publicado: (2021)

The Potential Influence of Advanced Glycation End Products and (s)RAGE in Rheumatic Diseases
por: Delrue, Charlotte, et al.
Publicado: (2023)

Links Between Obesity-Induced Brain Insulin Resistance, Brain Mitochondrial Dysfunction, and Dementia
por: Sripetchwandee, Jirapas, et al.
Publicado: (2018)

The Role of Receptor for Advanced Glycation End Products (RAGE) in the Proliferation of Hepatocellular Carcinoma
por: Yaser, Al-Madhagi, et al.
Publicado: (2012)

The Receptor for Advanced Glycation End Products (RAGE) Contributes to the Progression of Emphysema in Mice
por: Sambamurthy, Nisha, et al.
Publicado: (2015)

The Receptor for Advanced Glycation End Products (RAGE) Is Associated with Persistent Atrial Fibrillation
por: Lancefield, Terase F., et al.
Publicado: (2016)

Receptor for advanced glycation end-products (RAGE) mediates phagocytosis in nonprofessional phagocytes
por: Yang, Yan, et al.
Publicado: (2022)

Receptor for the Advanced Glycation End Products (RAGE) Pathway in Adipose Tissue Metabolism
por: Gutowska, Klaudia, et al.
Publicado: (2023)

Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE Ligands
por: Yao, Dachun, et al.
Publicado: (2010)

Prospective evaluation of serum biomarker levels and cartilage repair by autologous chondrocyte transplantation and subchondral drilling in a canine model
por: Nganvongpanit, Korakot, et al.
Publicado: (2009)

Osteosarcoma-Specific Genes as a Diagnostic Tool and Clinical Predictor of Tumor Progression
por: Sittiju, Pattaralawan, et al.
Publicado: (2022)

In vitro suppression of the MMP-3 gene in normal and cytokine-treated human chondrosarcoma using small interfering RNA
por: Nganvongpanit, Korakot, et al.
Publicado: (2009)

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
por: Soro-Paavonen, Aino, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_18cb4ib376g13km81i5m7lc06e